Chris Takimoto
Chief Tech/Sci/R&D Officer bij IGM BIOSCIENCES, INC.
Vermogen: 910 844 $ op 31-03-2024
Profiel
Chris H.
Takimoto is currently the Chief Medical Officer at IGM Biosciences, Inc. He previously held senior positions at Gilead Sciences, Inc., Forty Seven, Inc., Ortho Biotech Oncology Research & Development, and Janssen Global Services LLC.
He also worked as an Associate Professor at the University of Texas Health Science Center at San Antonio.
Takimoto received his undergraduate degree from Stanford University and his doctorate from Yale University and the Yale School of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
IGM BIOSCIENCES, INC.
0.28% | 14-03-2024 | 94 388 ( 0.28% ) | 910 844 $ | 31-03-2024 |
Actieve functies van Chris Takimoto
| Bedrijven | Functie | Begin |
|---|---|---|
| IGM BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 29-07-2021 |
Eerdere bekende functies van Chris Takimoto
| Bedrijven | Functie | Einde |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01-07-2021 |
| FORTY SEVEN, INC. | Chief Tech/Sci/R&D Officer | 01-04-2020 |
Janssen Global Services LLC
 Janssen Global Services LLC Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen Global Services LLC develops treatments for patients in therapeutic areas of healthcare. The private company is based in Raritan, NJ. | Corporate Officer/Principal | 01-01-2016 |
| Ortho Biotech Oncology Research & Development | Corporate Officer/Principal | 01-01-2010 |
| University of Texas Health Science Center At San Antonio | Corporate Officer/Principal | - |
Opleiding van Chris Takimoto
| Stanford University | Undergraduate Degree |
| Yale University | Doctorate Degree |
| Yale School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Forty Seven, Inc.
 Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA. | Health Technology |
| IGM Biosciences, Inc. | |
| Ortho Biotech Oncology Research & Development | |
Janssen Global Services LLC
Janssen Global Services LLC Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen Global Services LLC develops treatments for patients in therapeutic areas of healthcare. The private company is based in Raritan, NJ. | Health Technology |
